Now with over twenty FDA-approved small molecules, the field of kinase inhibition has matured. The sixth 欧美AV/SCI symposium on kinases will encompass case studies of on-going programmes as well as successful past kinase programmes, with examples from the CNS, inflammation/respiratory and oncology fields being presented. The question of emerging resistance to kinase inhibitors will be raised along with techniques being developed to address this. The symposium will also include views, perspectives and discussions on the future of kinase inhibitor research.
Kinase 2014: past, present and beyond. 6th 欧美AV / SCI symposium on kinase inhibitor design
19 - 20 May 2014, Cambridge, United Kingdom
Introduction
Sponsorship & supporting organisations
Argenta, AstraZeneca, Axxam, BioFocus, GlaxoSmithKline, Pfizer Neusentis, Sygnature Discovery
Venue
Babraham Research Campus
Babraham Research Campus, Babraham Hall, Babraham, Cambridge, CB22 3AT, United Kingdom
Useful links
Organised by
SCI - FCG
Contact information
Search
Advertisement
Spotlight
Explore
Membership
